Clinical Trials

A Phase 1 Dose-Escalation and Cohort-Expansion Study of VLS-101 in Hematological Malignancies

This clinical trial a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of the novel drug, VLS-101. The trial is assessing VLS-101 monotherapy across a range of dose levels when administered to patients with previously treated hematologic cancers. More details are available at ClinicalTrials.gov or by contacting us.